Study of a Pembrolizumab-based Organ Preservation Strategy for Locally Advanced Larynx Cancers

Clinical trial NCT04943445 · ACTIVE_NOT_RECRUITING

Trial details

NCT number

NCT04943445

Sponsor

Latin American Cooperative Oncology Group

Status

ACTIVE_NOT_RECRUITING

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2022-02-22

Primary completion

2025-10-16

Enrollment

43

View on ClinicalTrials.gov